Drug Type Small molecule drug |
Synonyms ASN 001, ASN001 |
Target |
Mechanism CYP17A1 inhibitors(Steroid 17-alpha-hydroxylase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization Asana BioSciences LLCStartup |
Active Organization Asana BioSciences LLCStartup |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC16H13FN2OS |
InChIKeyAQVYQEWAZCIHMU-UHFFFAOYSA-N |
CAS Registry1429329-63-4 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Prostatic Cancer | Phase 2 | - | Asana BioSciences LLCStartup | - |
Metastatic castration-resistant prostate cancer | Phase 1 | US | Asana BioSciences LLCStartup | 19 Jan 2015 |